Jci_page_head_homepage_01 Jci_page_head_homepage_02
Liangyou Rui
Published in Volume 117, Issue 2
J Clin Invest. 2007; 117(2):310 doi:10.1172/JCI31289
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2011 2010 2007 Total
Citations: 4 1 1 6

Citations to this article in CrossRef (6)

Title and authors Publication Year
Positive regulation of inositol 1,4,5-trisphosphate-induced ca2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells
Marc-Olivier Frégeau, Yannik Régimbald-Dumas, Gaétan Guillemette
J. Cell. Biochem. 2011
Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
Renato X. Santos, Sónia C. Correia, Susana Cardoso, Cristina Carvalho, Maria S. Santos, Paula I. Moreira
Journal of Neurochemistry 2011
Metabolic syndrome as a risk factor for neurological disorders
Akhlaq A. Farooqui, Tahira Farooqui, Francesco Panza, Vincenza Frisardi
Cell. Mol. Life Sci. 2011
Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin : mTOR Inhibitors and Outcomes
M. Z. Molnar, T. Isakova, M. E. Czira, C. P. Kovesdy, D. Roth, I. Mucsi, M. Wolf, F. Cortazar
Am J Transplant 2011
The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats
Maria Flaquer, Núria Lloberas, Marcella Franquesa, Joan Torras, August Vidal, Jose Luis Rosa, Immaculada Herrero-Fresneda, Josep M Grinyó, Josep M Cruzado
Life Sciences 2010
Adipose stress-sensing kinases: linking obesity to malfunction
Assaf Rudich, Hannah Kanety, Nava Bashan
Trends in Endocrinology & Metabolism 2007